Movantik FDA Approval History
FDA Approved: Yes (First approved September 16, 2014)
Brand name: Movantik
Generic name: naloxegol
Dosage form: Tablets
Treatment for: Constipation
Movantik (naloxegol) is a peripherally-acting mu-opioid receptor antagonist indicated for the treatment of opioid-induced constipation.
Development timeline for Movantik
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.